Business Context and Reporting Period
This Form 8-K was filed by Eyenovia, Inc. (trading symbol: EYEN) on November 22, 2024. The filing reports material definitive agreements regarding debt restructuring and equity issuance, as well as significant changes in executive leadership. Note: The request metadata referenced "HYPERION DEFI, INC.", but the filing text explicitly identifies the registrant as Eyenovia, Inc.
Key Financial Metrics and Agreements
- Debt Obligations: As of November 19, 2024, the Company owed $10.1 million in principal and accrued interest under a Loan and Security Agreement with Avenue Capital Management.
- Interest Rate: Outstanding amounts bear interest at the greater of 7.0% or the prime rate plus 4.45%.
- Maturity Date: The original maturity date is November 1, 2025.
- Equity Issuance: The Company agreed to issue 1,901,733 shares of common stock to the Lenders at approximately $0.1052 per share.
- Liquidity Impact: Principal and interest payments have been deferred until the end of February 2025.
Material Changes
- Debt Restructuring: The Company entered into a First Amendment to its Loan and Security Agreement, deferring all principal and interest payments until February 2025. Deferred interest will continue to accrue.
- Executive Transition: Andrew D. Jones transitioned out of his roles as Chief Financial Officer, Treasurer, and Secretary effective November 22, 2024. He will serve as a part-time consultant until December 31, 2024, for a fee of $20,000.
- Leadership Appointment: Michael Rowe, the Chief Executive Officer, was appointed as the new Principal Financial Officer, Treasurer, and Secretary.
Outlook, Risks, and Management Commentary
- Management Commentary: The departure of Mr. Jones is part of a restructuring process. The Company stated there were no disagreements regarding operations, policies, or accounting practices.
- Equity Issuance Timing: The issuance of shares to lenders is expected to occur on or around November 25, 2024, and is exempt from registration under the Securities Act of 1933.
- Risks: The deferral of payments extends the cash runway but increases the total debt burden due to accruing interest. The dilution from the issuance of ~1.9 million shares may impact existing shareholders.
Investor Verification Checklist
- Verify the exact dilution impact of the 1,901,733 shares issued at $0.1052 per share on the current share count.
- Confirm the total accrued interest amount as of the February 2025 payment deadline.
- Review the full text of the First Amendment (Exhibit 10.1) for any new covenants or default triggers.
- Monitor the Company's cash burn rate to ensure liquidity sufficiency through the February 2025 payment deferral period.
- Check for any subsequent filings regarding the finalization of the equity issuance.